As described by the management team, greenrush offers thousands of cannabis products for medicinal and recreational use through its mobile-first platform, helping new and existing cannabis consumers discover the right products for their needs. greenrush currently serves tens of thousands of consumers in hundreds of cities across the country while partnering with local dispensaries to broaden their customer base in local markets. Participation in greenrush’s Series B is available through RenGenLabs.com as of December 4, 2018.
“RenGen Labs is an ideal funding partner for greenrush at this pivotal moment in time for the cannabis industry,” said greenrush CEO, Paul Warshaw. “With evolving public sentiment and widespread adoption of cannabis, there is a rich opportunity in this space. We’re poised to scale rapidly given our strategic market position, proprietary technology platform and logistical expertise.”
To learn more about the greenrush investment opportunity, please visit https://www.rengenlabs.com/offerings/greenrush. Investors can sign up for updates and participate in the Series B offering after commencement on December 4, 2018. For payment instructions and information on how to participate in the offering, prospective investors should follow the prospective investor verification instructions.
ABOUT RENGEN LABS
RenGen Labs is a United States based company committed to providing investors with a secure and compliant platform for investing in private equity and security token offerings. RenGen Labs offers individuals and professionals a platform to connect with companies issuing private equity and security token offerings with secure accreditation and KYC/AML checks. More information is available at rengenlabs.com.
greenrush is a leading online cannabis marketplace that connects consumers with trusted local dispensary and delivery partners. greenrush is a mobile-first shopping experience built with new and existing cannabis users in mind. Its underlying technology platform currently provides on-demand eCommerce and delivery to its tens of thousands of customers from hundreds of dispensary partners. Consumers can shop from thousands of products in their area, no matter the need.
Certain statements and information in this communication may be deemed to be “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. The Company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance. Whether actual results will conform to expectations and predictions is subject to a variety of known and unknown risks and uncertainties, including the terms and timing of the private equity sale and security offering.
This press release is neither an offer to sell nor the solicitation of an offer to buy any securities, and no offer, solicitation or sale will be made in any jurisdiction in which, or to any persons to whom, such an offer, solicitation or sale is unlawful.
The securities described herein have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from such registration requirements. This private equity offering, in particular, will only allow accredited investors to participate under Rule 506(c) of the JOBS Act.
Contact: Brian Johnson, email@example.com
SOURCE RenGen Labs